Astellas Says First-Half Profit Jumped 17& to 51.3 Billion Yen

Astellas Pharma Inc. (4503), Japan’s third- largest drugmaker, reported first-half profit increased 17 percent to 51.3 billion yen in a statement to the Tokyo Stock Exchange today.

To contact the reporter on this story: Kanoko Matsuyama in Tokyo at kmatsuyama2@bloomberg.net

To contact the editor responsible for this story: Jason Gale at j.gale@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.